UM
(Note: the search results are based on claimed items)

Browse/Search Results:  1-3 of 3 Help

Filters            
Selected(0)Clear Items/Page:    Sort:
Research and development of anti-Alzheimer's disease drugs: an update from the perspective of technology flows Journal article
EXPERT OPINION ON THERAPEUTIC PATENTS, 2018,Volume: 28,Issue: 4,Page: 341-350
Authors:  Liu, Kunmeng;  Lin, Hui-Heng;  Pi, Rongbiao;  Mak, Shinghung;  Han, Yifan;  Hu, Yuanjia
Favorite  |  View/Download:2/0  |  Submit date:2018/10/31
Alzheimer's disease  patent  technology flow  citation network  research and development  
Global patent landscape of programmed cell death 1: implications of the rapid expansion Journal article
EXPERT OPINION ON THERAPEUTIC PATENTS, 2018,Volume: 28,Issue: 1,Page: 69-80
Authors:  Kong, Xiangjun;  Zhang, Qianru;  Lai, Yunfeng;  Hu, Hao;  Chen, Xin;  Hu, Yuanjia
Favorite  |  View/Download:14/0  |  Submit date:2018/10/30
Programmed Cell Death 1 (Pd-1)  Patent Landscape  Patent Citation Network  Co-patent  Technology Flow  Immunotherapy  
Evolving patterns in a collaboration network of global R&D on monoclonal antibodies Journal article
MABS, 2017,Volume: 9,Issue: 7,Page: 1041-1051
Authors:  Kong, Xiangjun;  Wan, Jian-bo;  Hu, Hao;  Su, Shibing;  Hu, Yuanjia
Favorite  |  View/Download:8/0  |  Submit date:2018/10/30
Collaboration Network  Dedicated Biotechnology Firms  Inter-organizational Relationship  Mergers And Acquisitions  Monoclonal Antibodies  Network Evolution  r&d  Pharmaceutical Companies  Technological Innovation